Natural Alternatives International (NASDAQ:NAII) Now Covered by StockNews.com

Equities research analysts at StockNews.com began coverage on shares of Natural Alternatives International (NASDAQ:NAII) in a research note issued on Monday. The brokerage set a “buy” rating on the stock.

Natural Alternatives International Price Performance

Shares of NASDAQ NAII opened at $4.53 on Monday. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.56 and a quick ratio of 1.59. The company has a market cap of $28.09 million, a P/E ratio of -3.15 and a beta of 0.58. Natural Alternatives International has a 1 year low of $4.13 and a 1 year high of $7.37. The firm has a 50-day simple moving average of $5.17 and a two-hundred day simple moving average of $5.72.

Natural Alternatives International (NASDAQ:NAII) last announced its quarterly earnings data on Friday, September 27th. The company reported ($0.32) earnings per share (EPS) for the quarter. The firm had revenue of $29.49 million during the quarter. Natural Alternatives International had a negative return on equity of 10.23% and a negative net margin of 7.53%.

Hedge Funds Weigh In On Natural Alternatives International

A hedge fund recently raised its stake in Natural Alternatives International stock. Geode Capital Management LLC lifted its stake in shares of Natural Alternatives International, Inc. (NASDAQ:NAII) by 6.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 45,062 shares of the company’s stock after acquiring an additional 2,915 shares during the quarter. Geode Capital Management LLC owned approximately 0.73% of Natural Alternatives International worth $258,000 at the end of the most recent reporting period. 32.40% of the stock is currently owned by hedge funds and other institutional investors.

About Natural Alternatives International

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.